Log in to save to my catalogue

The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control stud...

The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control stud...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d43098c14d8f4cb087d06ce022c9cc58

The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study

About this item

Full title

The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study

Publisher

England: BioMed Central Ltd

Journal title

Respiratory research, 2019-12, Vol.20 (1), p.283-283, Article 283

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

There are limited data available on whether drug-induced hepatotoxicity (DIH) affects the clinical outcomes of tuberculosis (TB) treatment. We explored the effects of DIH on the clinical course and outcomes of pulmonary TB.
In this retrospective cohort study, we included patients with culture-proven pulmonary TB treated in a tertiary hospital fr...

Alternative Titles

Full title

The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d43098c14d8f4cb087d06ce022c9cc58

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d43098c14d8f4cb087d06ce022c9cc58

Other Identifiers

ISSN

1465-993X,1465-9921

E-ISSN

1465-993X,1465-9921

DOI

10.1186/s12931-019-1256-y

How to access this item